 Kinaxis (TSE:KXS – Get Free Report) had its target price boosted by CIBC  from C$198.00 to C$201.00 in a report released on Wednesday,BayStreet.CA reports. The firm presently has a “neutral” rating on the stock. CIBC’s price target would suggest a potential upside of 19.17% from the company’s current price.
Kinaxis (TSE:KXS – Get Free Report) had its target price boosted by CIBC  from C$198.00 to C$201.00 in a report released on Wednesday,BayStreet.CA reports. The firm presently has a “neutral” rating on the stock. CIBC’s price target would suggest a potential upside of 19.17% from the company’s current price.
Other equities analysts also recently issued research reports about the company. Scotiabank increased their price objective on Kinaxis from C$225.00 to C$240.00 and gave the stock an “outperform” rating in a report on Friday, August 8th. TD Securities lifted their target price on shares of Kinaxis from C$190.00 to C$225.00 and gave the stock a “buy” rating in a report on Friday, October 3rd. National Bankshares set a C$240.00 price target on Kinaxis and gave the company an “outperform” rating in a report on Thursday, October 23rd. Royal Bank Of Canada upped their price target on Kinaxis from C$225.00 to C$235.00 in a report on Friday, August 8th. Finally, Stifel Nicolaus increased their target price on Kinaxis from C$225.00 to C$245.00 and gave the company a “buy” rating in a report on Thursday, July 31st. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Kinaxis has an average rating of “Moderate Buy” and a consensus target price of C$227.63.
Check Out Our Latest Stock Report on Kinaxis
Kinaxis Price Performance
Insider Buying and Selling at Kinaxis
In other news, insider Mark Justin Morgan sold 2,281 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of C$198.63, for a total value of C$453,081.87. Following the completion of the sale, the insider directly owned 11,000 shares of the company’s stock, valued at C$2,184,963. This trade represents a 17.17% decrease in their position. Also, insider Andrew William Robert Bell sold 275 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of C$193.18, for a total value of C$53,124.50. Following the completion of the sale, the insider directly owned 1,919 shares of the company’s stock, valued at C$370,712.42. The trade was a 12.53% decrease in their ownership of the stock. Insiders sold 8,656 shares of company stock worth $1,665,206 in the last quarter. 1.20% of the stock is owned by corporate insiders.
Kinaxis Company Profile
Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm’s flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.
Featured Stories
- Five stocks we like better than Kinaxis
- How to Calculate Stock Profit
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- What Are Some of the Best Large-Cap Stocks to Buy?
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- Why Are These Companies Considered Blue Chips?
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
